Revance Therapeutics, Inc. $2,785,818 Glaukos Corp $3,961,393 Si-Bone, Inc. $0 Revance Therapeutics, Inc. $2,785,818 Glaukos Corp $3,961,393 Si-Bone, Inc. $0